世界のエストロゲン受容体ベータ市場インサイト及び予測(~2026年)

【英語タイトル】Global Estrogen Receptor Beta Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV05803)・商品コード:QYR20NV05803
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:112
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはエストロゲン受容体ベータの世界市場について調査・分析した資料です。種類別(エルテベレル、エステトロール、ホスフェストロール、フルベストラント、その他)の市場規模、用途別(女性健康、代謝障害、皮膚科、免疫学、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別エストロゲン受容体ベータの競争状況、市場シェア
・世界のエストロゲン受容体ベータ市場:種類別市場規模 2015年-2020年(エルテベレル、エステトロール、ホスフェストロール、フルベストラント、その他)
・世界のエストロゲン受容体ベータ市場:種類別市場規模予測 2021年-2026年(エルテベレル、エステトロール、ホスフェストロール、フルベストラント、その他)
・世界のエストロゲン受容体ベータ市場:用途別市場規模 2015年-2020年(女性健康、代謝障害、皮膚科、免疫学、その他)
・世界のエストロゲン受容体ベータ市場:用途別市場規模予測 2021年-2026年(女性健康、代謝障害、皮膚科、免疫学、その他)
・北米のエストロゲン受容体ベータ市場分析:米国、カナダ
・ヨーロッパのエストロゲン受容体ベータ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのエストロゲン受容体ベータ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のエストロゲン受容体ベータ市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのエストロゲン受容体ベータ市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Acadia Pharmaceuticals Inc、AstraZeneca Plc、Atossa Genetics Inc、Chamaeleo Pharma NV、Eli Lilly and Company、Endece LLC、EndoCeutics Inc、Karo Pharma AB、Kissei Pharmaceutical Co Ltd、MEI Pharma Inc、Mithra Pharmaceuticals SA、Oasmia Pharmaceutical AB
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Estrogen Receptor Beta Market
The global Estrogen Receptor Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Estrogen Receptor Beta Scope and Market Size
Estrogen Receptor Beta market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Estrogen Receptor Beta market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Estrogen Receptor Beta market is segmented into
Erteberel
Estetrol
Fosfestrol
Fulvestrant
Others

Segment by Application, the Estrogen Receptor Beta market is segmented into
Women’s Health
Metabolic Disorder
Dermatology
Immunology
Others

Regional and Country-level Analysis
The Estrogen Receptor Beta market is analysed and market size information is provided by regions (countries).
The key regions covered in the Estrogen Receptor Beta market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Estrogen Receptor Beta Market Share Analysis
Estrogen Receptor Beta market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Estrogen Receptor Beta business, the date to enter into the Estrogen Receptor Beta market, Estrogen Receptor Beta product introduction, recent developments, etc.

The major vendors covered:
Acadia Pharmaceuticals Inc
AstraZeneca Plc
Atossa Genetics Inc
Chamaeleo Pharma NV
Eli Lilly and Company
Endece LLC
EndoCeutics Inc
Karo Pharma AB
Kissei Pharmaceutical Co Ltd
MEI Pharma Inc
Mithra Pharmaceuticals SA
Oasmia Pharmaceutical AB

【レポートの目次】

1 Study Coverage
1.1 Estrogen Receptor Beta Product Introduction
1.2 Market Segments
1.3 Key Estrogen Receptor Beta Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Estrogen Receptor Beta Market Size Growth Rate by Type
1.4.2 Erteberel
1.4.3 Estetrol
1.4.4 Fosfestrol
1.4.5 Fulvestrant
1.4.6 Others
1.5 Market by Application
1.5.1 Global Estrogen Receptor Beta Market Size Growth Rate by Application
1.5.2 Women’s Health
1.5.3 Metabolic Disorder
1.5.4 Dermatology
1.5.5 Immunology
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Estrogen Receptor Beta Market Size, Estimates and Forecasts
2.1.1 Global Estrogen Receptor Beta Revenue 2015-2026
2.1.2 Global Estrogen Receptor Beta Sales 2015-2026
2.2 Global Estrogen Receptor Beta, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Estrogen Receptor Beta Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Estrogen Receptor Beta Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Estrogen Receptor Beta Competitor Landscape by Players
3.1 Estrogen Receptor Beta Sales by Manufacturers
3.1.1 Estrogen Receptor Beta Sales by Manufacturers (2015-2020)
3.1.2 Estrogen Receptor Beta Sales Market Share by Manufacturers (2015-2020)
3.2 Estrogen Receptor Beta Revenue by Manufacturers
3.2.1 Estrogen Receptor Beta Revenue by Manufacturers (2015-2020)
3.2.2 Estrogen Receptor Beta Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Estrogen Receptor Beta Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Estrogen Receptor Beta Revenue in 2019
3.2.5 Global Estrogen Receptor Beta Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Estrogen Receptor Beta Price by Manufacturers
3.4 Estrogen Receptor Beta Manufacturing Base Distribution, Product Types
3.4.1 Estrogen Receptor Beta Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Estrogen Receptor Beta Product Type
3.4.3 Date of International Manufacturers Enter into Estrogen Receptor Beta Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Estrogen Receptor Beta Market Size by Type (2015-2020)
4.1.1 Global Estrogen Receptor Beta Sales by Type (2015-2020)
4.1.2 Global Estrogen Receptor Beta Revenue by Type (2015-2020)
4.1.3 Estrogen Receptor Beta Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Estrogen Receptor Beta Market Size Forecast by Type (2021-2026)
4.2.1 Global Estrogen Receptor Beta Sales Forecast by Type (2021-2026)
4.2.2 Global Estrogen Receptor Beta Revenue Forecast by Type (2021-2026)
4.2.3 Estrogen Receptor Beta Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Estrogen Receptor Beta Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Estrogen Receptor Beta Market Size by Application (2015-2020)
5.1.1 Global Estrogen Receptor Beta Sales by Application (2015-2020)
5.1.2 Global Estrogen Receptor Beta Revenue by Application (2015-2020)
5.1.3 Estrogen Receptor Beta Price by Application (2015-2020)
5.2 Estrogen Receptor Beta Market Size Forecast by Application (2021-2026)
5.2.1 Global Estrogen Receptor Beta Sales Forecast by Application (2021-2026)
5.2.2 Global Estrogen Receptor Beta Revenue Forecast by Application (2021-2026)
5.2.3 Global Estrogen Receptor Beta Price Forecast by Application (2021-2026)

6 North America
6.1 North America Estrogen Receptor Beta by Country
6.1.1 North America Estrogen Receptor Beta Sales by Country
6.1.2 North America Estrogen Receptor Beta Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Estrogen Receptor Beta Market Facts & Figures by Type
6.3 North America Estrogen Receptor Beta Market Facts & Figures by Application

7 Europe
7.1 Europe Estrogen Receptor Beta by Country
7.1.1 Europe Estrogen Receptor Beta Sales by Country
7.1.2 Europe Estrogen Receptor Beta Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Estrogen Receptor Beta Market Facts & Figures by Type
7.3 Europe Estrogen Receptor Beta Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Estrogen Receptor Beta by Region
8.1.1 Asia Pacific Estrogen Receptor Beta Sales by Region
8.1.2 Asia Pacific Estrogen Receptor Beta Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Estrogen Receptor Beta Market Facts & Figures by Type
8.3 Asia Pacific Estrogen Receptor Beta Market Facts & Figures by Application

9 Latin America
9.1 Latin America Estrogen Receptor Beta by Country
9.1.1 Latin America Estrogen Receptor Beta Sales by Country
9.1.2 Latin America Estrogen Receptor Beta Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Estrogen Receptor Beta Market Facts & Figures by Type
9.3 Central & South America Estrogen Receptor Beta Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Estrogen Receptor Beta by Country
10.1.1 Middle East and Africa Estrogen Receptor Beta Sales by Country
10.1.2 Middle East and Africa Estrogen Receptor Beta Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Estrogen Receptor Beta Market Facts & Figures by Type
10.3 Middle East and Africa Estrogen Receptor Beta Market Facts & Figures by Application

11 Company Profiles
11.1 Acadia Pharmaceuticals Inc
11.1.1 Acadia Pharmaceuticals Inc Corporation Information
11.1.2 Acadia Pharmaceuticals Inc Description and Business Overview
11.1.3 Acadia Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acadia Pharmaceuticals Inc Estrogen Receptor Beta Products Offered
11.1.5 Acadia Pharmaceuticals Inc Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Estrogen Receptor Beta Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 Atossa Genetics Inc
11.3.1 Atossa Genetics Inc Corporation Information
11.3.2 Atossa Genetics Inc Description and Business Overview
11.3.3 Atossa Genetics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Atossa Genetics Inc Estrogen Receptor Beta Products Offered
11.3.5 Atossa Genetics Inc Related Developments
11.4 Chamaeleo Pharma NV
11.4.1 Chamaeleo Pharma NV Corporation Information
11.4.2 Chamaeleo Pharma NV Description and Business Overview
11.4.3 Chamaeleo Pharma NV Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Chamaeleo Pharma NV Estrogen Receptor Beta Products Offered
11.4.5 Chamaeleo Pharma NV Related Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Description and Business Overview
11.5.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eli Lilly and Company Estrogen Receptor Beta Products Offered
11.5.5 Eli Lilly and Company Related Developments
11.6 Endece LLC
11.6.1 Endece LLC Corporation Information
11.6.2 Endece LLC Description and Business Overview
11.6.3 Endece LLC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Endece LLC Estrogen Receptor Beta Products Offered
11.6.5 Endece LLC Related Developments
11.7 EndoCeutics Inc
11.7.1 EndoCeutics Inc Corporation Information
11.7.2 EndoCeutics Inc Description and Business Overview
11.7.3 EndoCeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 EndoCeutics Inc Estrogen Receptor Beta Products Offered
11.7.5 EndoCeutics Inc Related Developments
11.8 Karo Pharma AB
11.8.1 Karo Pharma AB Corporation Information
11.8.2 Karo Pharma AB Description and Business Overview
11.8.3 Karo Pharma AB Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Karo Pharma AB Estrogen Receptor Beta Products Offered
11.8.5 Karo Pharma AB Related Developments
11.9 Kissei Pharmaceutical Co Ltd
11.9.1 Kissei Pharmaceutical Co Ltd Corporation Information
11.9.2 Kissei Pharmaceutical Co Ltd Description and Business Overview
11.9.3 Kissei Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Kissei Pharmaceutical Co Ltd Estrogen Receptor Beta Products Offered
11.9.5 Kissei Pharmaceutical Co Ltd Related Developments
11.10 MEI Pharma Inc
11.10.1 MEI Pharma Inc Corporation Information
11.10.2 MEI Pharma Inc Description and Business Overview
11.10.3 MEI Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MEI Pharma Inc Estrogen Receptor Beta Products Offered
11.10.5 MEI Pharma Inc Related Developments
11.1 Acadia Pharmaceuticals Inc
11.1.1 Acadia Pharmaceuticals Inc Corporation Information
11.1.2 Acadia Pharmaceuticals Inc Description and Business Overview
11.1.3 Acadia Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Acadia Pharmaceuticals Inc Estrogen Receptor Beta Products Offered
11.1.5 Acadia Pharmaceuticals Inc Related Developments
11.12 Oasmia Pharmaceutical AB
11.12.1 Oasmia Pharmaceutical AB Corporation Information
11.12.2 Oasmia Pharmaceutical AB Description and Business Overview
11.12.3 Oasmia Pharmaceutical AB Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Oasmia Pharmaceutical AB Products Offered
11.12.5 Oasmia Pharmaceutical AB Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Estrogen Receptor Beta Market Estimates and Projections by Region
12.1.1 Global Estrogen Receptor Beta Sales Forecast by Regions 2021-2026
12.1.2 Global Estrogen Receptor Beta Revenue Forecast by Regions 2021-2026
12.2 North America Estrogen Receptor Beta Market Size Forecast (2021-2026)
12.2.1 North America: Estrogen Receptor Beta Sales Forecast (2021-2026)
12.2.2 North America: Estrogen Receptor Beta Revenue Forecast (2021-2026)
12.2.3 North America: Estrogen Receptor Beta Market Size Forecast by Country (2021-2026)
12.3 Europe Estrogen Receptor Beta Market Size Forecast (2021-2026)
12.3.1 Europe: Estrogen Receptor Beta Sales Forecast (2021-2026)
12.3.2 Europe: Estrogen Receptor Beta Revenue Forecast (2021-2026)
12.3.3 Europe: Estrogen Receptor Beta Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Estrogen Receptor Beta Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Estrogen Receptor Beta Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Estrogen Receptor Beta Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Estrogen Receptor Beta Market Size Forecast by Region (2021-2026)
12.5 Latin America Estrogen Receptor Beta Market Size Forecast (2021-2026)
12.5.1 Latin America: Estrogen Receptor Beta Sales Forecast (2021-2026)
12.5.2 Latin America: Estrogen Receptor Beta Revenue Forecast (2021-2026)
12.5.3 Latin America: Estrogen Receptor Beta Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Estrogen Receptor Beta Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Estrogen Receptor Beta Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Estrogen Receptor Beta Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Estrogen Receptor Beta Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Estrogen Receptor Beta Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Estrogen Receptor Beta Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Estrogen Receptor Beta Market Segments
Table 2. Ranking of Global Top Estrogen Receptor Beta Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Estrogen Receptor Beta Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Erteberel
Table 5. Major Manufacturers of Estetrol
Table 6. Major Manufacturers of Fosfestrol
Table 7. Major Manufacturers of Fulvestrant
Table 8. Major Manufacturers of Others
Table 9. Global Estrogen Receptor Beta Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Estrogen Receptor Beta Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Estrogen Receptor Beta Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Estrogen Receptor Beta Sales Market Share by Regions (2015-2020)
Table 13. Global Estrogen Receptor Beta Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Estrogen Receptor Beta Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Estrogen Receptor Beta Sales Share by Manufacturers (2015-2020)
Table 16. Global Estrogen Receptor Beta Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Estrogen Receptor Beta by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Estrogen Receptor Beta as of 2019)
Table 18. Estrogen Receptor Beta Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Estrogen Receptor Beta Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Estrogen Receptor Beta Price (2015-2020) (USD/Pcs)
Table 21. Estrogen Receptor Beta Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Estrogen Receptor Beta Product Type
Table 23. Date of International Manufacturers Enter into Estrogen Receptor Beta Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Estrogen Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 26. Global Estrogen Receptor Beta Sales Share by Type (2015-2020)
Table 27. Global Estrogen Receptor Beta Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Estrogen Receptor Beta Revenue Share by Type (2015-2020)
Table 29. Estrogen Receptor Beta Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Estrogen Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 31. Global Estrogen Receptor Beta Sales Share by Application (2015-2020)
Table 32. North America Estrogen Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 33. North America Estrogen Receptor Beta Sales Market Share by Country (2015-2020)
Table 34. North America Estrogen Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Estrogen Receptor Beta Revenue Market Share by Country (2015-2020)
Table 36. North America Estrogen Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 37. North America Estrogen Receptor Beta Sales Market Share by Type (2015-2020)
Table 38. North America Estrogen Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 39. North America Estrogen Receptor Beta Sales Market Share by Application (2015-2020)
Table 40. Europe Estrogen Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Estrogen Receptor Beta Sales Market Share by Country (2015-2020)
Table 42. Europe Estrogen Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Estrogen Receptor Beta Revenue Market Share by Country (2015-2020)
Table 44. Europe Estrogen Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Estrogen Receptor Beta Sales Market Share by Type (2015-2020)
Table 46. Europe Estrogen Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Estrogen Receptor Beta Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Estrogen Receptor Beta Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Estrogen Receptor Beta Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Estrogen Receptor Beta Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Estrogen Receptor Beta Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Estrogen Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Estrogen Receptor Beta Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Estrogen Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Estrogen Receptor Beta Sales Market Share by Application (2015-2020)
Table 56. Latin America Estrogen Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Estrogen Receptor Beta Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Estrogen Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Estrogen Receptor Beta Revenue Market Share by Country (2015-2020)
Table 60. Latin America Estrogen Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Estrogen Receptor Beta Sales Market Share by Type (2015-2020)
Table 62. Latin America Estrogen Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Estrogen Receptor Beta Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Estrogen Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Estrogen Receptor Beta Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Estrogen Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Estrogen Receptor Beta Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Estrogen Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Estrogen Receptor Beta Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Estrogen Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Estrogen Receptor Beta Sales Market Share by Application (2015-2020)
Table 72. Acadia Pharmaceuticals Inc Corporation Information
Table 73. Acadia Pharmaceuticals Inc Description and Major Businesses
Table 74. Acadia Pharmaceuticals Inc Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Acadia Pharmaceuticals Inc Product
Table 76. Acadia Pharmaceuticals Inc Recent Development
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Major Businesses
Table 79. AstraZeneca Plc Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Product
Table 81. AstraZeneca Plc Recent Development
Table 82. Atossa Genetics Inc Corporation Information
Table 83. Atossa Genetics Inc Description and Major Businesses
Table 84. Atossa Genetics Inc Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Atossa Genetics Inc Product
Table 86. Atossa Genetics Inc Recent Development
Table 87. Chamaeleo Pharma NV Corporation Information
Table 88. Chamaeleo Pharma NV Description and Major Businesses
Table 89. Chamaeleo Pharma NV Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Chamaeleo Pharma NV Product
Table 91. Chamaeleo Pharma NV Recent Development
Table 92. Eli Lilly and Company Corporation Information
Table 93. Eli Lilly and Company Description and Major Businesses
Table 94. Eli Lilly and Company Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Eli Lilly and Company Product
Table 96. Eli Lilly and Company Recent Development
Table 97. Endece LLC Corporation Information
Table 98. Endece LLC Description and Major Businesses
Table 99. Endece LLC Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Endece LLC Product
Table 101. Endece LLC Recent Development
Table 102. EndoCeutics Inc Corporation Information
Table 103. EndoCeutics Inc Description and Major Businesses
Table 104. EndoCeutics Inc Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. EndoCeutics Inc Product
Table 106. EndoCeutics Inc Recent Development
Table 107. Karo Pharma AB Corporation Information
Table 108. Karo Pharma AB Description and Major Businesses
Table 109. Karo Pharma AB Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Karo Pharma AB Product
Table 111. Karo Pharma AB Recent Development
Table 112. Kissei Pharmaceutical Co Ltd Corporation Information
Table 113. Kissei Pharmaceutical Co Ltd Description and Major Businesses
Table 114. Kissei Pharmaceutical Co Ltd Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Kissei Pharmaceutical Co Ltd Product
Table 116. Kissei Pharmaceutical Co Ltd Recent Development
Table 117. MEI Pharma Inc Corporation Information
Table 118. MEI Pharma Inc Description and Major Businesses
Table 119. MEI Pharma Inc Estrogen Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. MEI Pharma Inc Product
Table 121. MEI Pharma Inc Recent Development
Table 122. Mithra Pharmaceuticals SA Corporation Information
Table 123. Mithra Pharmaceuticals SA Description and Major Businesses
Table 124. Mithra Pharmaceuticals SA Estrogen Receptor Beta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Mithra Pharmaceuticals SA Product
Table 126. Mithra Pharmaceuticals SA Recent Development
Table 127. Oasmia Pharmaceutical AB Corporation Information
Table 128. Oasmia Pharmaceutical AB Description and Major Businesses
Table 129. Oasmia Pharmaceutical AB Estrogen Receptor Beta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Oasmia Pharmaceutical AB Product
Table 131. Oasmia Pharmaceutical AB Recent Development
Table 132. Global Estrogen Receptor Beta Sales Forecast by Regions (2021-2026) (K Pcs)
Table 133. Global Estrogen Receptor Beta Sales Market Share Forecast by Regions (2021-2026)
Table 134. Global Estrogen Receptor Beta Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 135. Global Estrogen Receptor Beta Revenue Market Share Forecast by Regions (2021-2026)
Table 136. North America: Estrogen Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. North America: Estrogen Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Europe: Estrogen Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Europe: Estrogen Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Asia Pacific: Estrogen Receptor Beta Sales Forecast by Region (2021-2026) (K Pcs)
Table 141. Asia Pacific: Estrogen Receptor Beta Revenue Forecast by Region (2021-2026) (US$ Million)
Table 142. Latin America: Estrogen Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Latin America: Estrogen Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Middle East and Africa: Estrogen Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. Middle East and Africa: Estrogen Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Estrogen Receptor Beta Players
Table 150. Estrogen Receptor Beta Customers List
Table 151. Estrogen Receptor Beta Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Estrogen Receptor Beta Product Picture
Figure 2. Global Estrogen Receptor Beta Sales Market Share by Type in 2020 & 2026
Figure 3. Erteberel Product Picture
Figure 4. Estetrol Product Picture
Figure 5. Fosfestrol Product Picture
Figure 6. Fulvestrant Product Picture
Figure 7. Others Product Picture
Figure 8. Global Estrogen Receptor Beta Sales Market Share by Application in 2020 & 2026
Figure 9. Women's Health
Figure 10. Metabolic Disorder
Figure 11. Dermatology
Figure 12. Immunology
Figure 13. Others
Figure 14. Estrogen Receptor Beta Report Years Considered
Figure 15. Global Estrogen Receptor Beta Market Size 2015-2026 (US$ Million)
Figure 16. Global Estrogen Receptor Beta Sales 2015-2026 (K Pcs)
Figure 17. Global Estrogen Receptor Beta Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Estrogen Receptor Beta Sales Market Share by Region (2015-2020)
Figure 19. Global Estrogen Receptor Beta Sales Market Share by Region in 2019
Figure 20. Global Estrogen Receptor Beta Revenue Market Share by Region (2015-2020)
Figure 21. Global Estrogen Receptor Beta Revenue Market Share by Region in 2019
Figure 22. Global Estrogen Receptor Beta Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Estrogen Receptor Beta Revenue in 2019
Figure 24. Estrogen Receptor Beta Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Estrogen Receptor Beta Sales Market Share by Type (2015-2020)
Figure 26. Global Estrogen Receptor Beta Sales Market Share by Type in 2019
Figure 27. Global Estrogen Receptor Beta Revenue Market Share by Type (2015-2020)
Figure 28. Global Estrogen Receptor Beta Revenue Market Share by Type in 2019
Figure 29. Global Estrogen Receptor Beta Market Share by Price Range (2015-2020)
Figure 30. Global Estrogen Receptor Beta Sales Market Share by Application (2015-2020)
Figure 31. Global Estrogen Receptor Beta Sales Market Share by Application in 2019
Figure 32. Global Estrogen Receptor Beta Revenue Market Share by Application (2015-2020)
Figure 33. Global Estrogen Receptor Beta Revenue Market Share by Application in 2019
Figure 34. North America Estrogen Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Estrogen Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Estrogen Receptor Beta Sales Market Share by Country in 2019
Figure 37. North America Estrogen Receptor Beta Revenue Market Share by Country in 2019
Figure 38. U.S. Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Estrogen Receptor Beta Market Share by Type in 2019
Figure 43. North America Estrogen Receptor Beta Market Share by Application in 2019
Figure 44. Europe Estrogen Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Estrogen Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Estrogen Receptor Beta Sales Market Share by Country in 2019
Figure 47. Europe Estrogen Receptor Beta Revenue Market Share by Country in 2019
Figure 48. Germany Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Estrogen Receptor Beta Market Share by Type in 2019
Figure 59. Europe Estrogen Receptor Beta Market Share by Application in 2019
Figure 60. Asia Pacific Estrogen Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Estrogen Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Estrogen Receptor Beta Sales Market Share by Region in 2019
Figure 63. Asia Pacific Estrogen Receptor Beta Revenue Market Share by Region in 2019
Figure 64. China Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Estrogen Receptor Beta Market Share by Type in 2019
Figure 87. Asia Pacific Estrogen Receptor Beta Market Share by Application in 2019
Figure 88. Latin America Estrogen Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Estrogen Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Estrogen Receptor Beta Sales Market Share by Country in 2019
Figure 91. Latin America Estrogen Receptor Beta Revenue Market Share by Country in 2019
Figure 92. Mexico Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Estrogen Receptor Beta Market Share by Type in 2019
Figure 99. Latin America Estrogen Receptor Beta Market Share by Application in 2019
Figure 100. Middle East and Africa Estrogen Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Estrogen Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Estrogen Receptor Beta Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Estrogen Receptor Beta Revenue Market Share by Country in 2019
Figure 104. Turkey Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Estrogen Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Estrogen Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Estrogen Receptor Beta Market Share by Type in 2019
Figure 111. Middle East and Africa Estrogen Receptor Beta Market Share by Application in 2019
Figure 112. North America Estrogen Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Estrogen Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Estrogen Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Estrogen Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Estrogen Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Estrogen Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Estrogen Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Estrogen Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Estrogen Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Estrogen Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed


【掲載企業】

Acadia Pharmaceuticals Inc、AstraZeneca Plc、Atossa Genetics Inc、Chamaeleo Pharma NV、Eli Lilly and Company、Endece LLC、EndoCeutics Inc、Karo Pharma AB、Kissei Pharmaceutical Co Ltd、MEI Pharma Inc、Mithra Pharmaceuticals SA、Oasmia Pharmaceutical AB

★調査レポート[世界のエストロゲン受容体ベータ市場インサイト及び予測(~2026年)] (コード:QYR20NV05803)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエストロゲン受容体ベータ市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆